Thomas Kleen, based in Berlin, DE, is currently a Chief Scientific Officer and Principal Consultant at BioLab Services LLC, bringing experience from previous roles at Immodulon Therapeutics Limited, Breakwater T Corporation, Precision For Medicine and Epiontis GmbH. Thomas Kleen holds a 2003 - 2004 Doctorates in Biochemistry, Biology, Immunology, Virology @ Julius-Maximilians-Universität Würzburg, Germany. With a robust skill set that includes Leadership, Early Stage Companies, Clinical Trials, Customer Relations, High Throughput Screening and more, Thomas Kleen contributes valuable insights to the industry. Thomas Kleen has 5 emails and 1 mobile phone number on RocketReach.